True or False: Ganglionic blockers are considered non-specific.

True or False: Ganglionic blockers are considered non-specific.

• A. True
• B. False
• C. Only in low doses
• D. Only in high doses

Answer: (A)

Ganglionic blockers are indeed considered non-specific because they inhibit neural transmission at autonomic ganglia in both the sympathetic and parasympathetic nervous systems. This means that they do not selectively target one branch of the autonomic system over the other; instead, they affect all ganglionic synapses regardless of their neurotransmitter type. As a result, the effects produced by ganglionic blockers can lead to a wide range of physiological responses impacting various organ systems due to their lack of selectivity. This characteristic distinguishes them from other agents that may have more targeted effects, making the assessment of their action in clinical settings complex and requiring careful monitoring of the overall physiological impact.

Ganglionic blockers are indeed considered non-specific because they inhibit neural transmission at autonomic ganglia in both the sympathetic and parasympathetic nervous systems. This means that they do not selectively target one branch of the autonomic system over the other; instead, they affect all ganglionic synapses regardless of their neurotransmitter type. As a result, the effects produced by ganglionic blockers can lead to a wide range of physiological responses impacting various organ systems due to their lack of selectivity. This characteristic distinguishes them from other agents that may have more targeted effects, making the assessment of their action in clinical settings complex and requiring careful monitoring of the overall physiological impact.